✦ LIBER ✦

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

✍ Scribed by Thomas Leemhuis; Sandra Wells; Christian Scheffold; Matthias Edinger; Robert S. Negrin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of denileukin diftitox fo

✍ Nam H. Dang; Barbara Pro; Fredrick B. Hagemeister; Felipe Samaniego; Dan Jones; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Phase I trial of fludarabine, bortezomib

✍ Paul M. Barr; Pingfu Fu; Hillard M. Lazarus; Nancy Horvath; Stanton L. Gerson; O 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The use of autologous LMP2-specific cyto

✍ C.M. Bollard; K.C. Straathof; H. Huls; V. Gresik; G. Carrum; S. Gottschalk; A. G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase I/II Study of Bortezomib-BEAM and

✍ William, Basem M.; Allen, Mary S.; Loberiza, Fausto R.; Bociek, Robert Gregory; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Phase I study of bortezomib plus ICE (BI

✍ Michelle Fanale; Luis Fayad; Barbara Pro; Felipe Samaniego; Mary Joy Liboon; Ces 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB